ProfileGDS4132 / 225434_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 91% 89% 90% 91% 89% 90% 89% 89% 87% 89% 86% 85% 87% 87% 82% 84% 84% 85% 87% 88% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101436.95991
GSM201543Muscle PCOS pioglitazone 121364.40389
GSM201544Muscle PCOS pioglitazone 161464.91390
GSM201545Muscle PCOS pioglitazone 201493.58691
GSM201829Muscle PCOS pioglitazone 231409.42489
GSM201830Muscle PCOS pioglitazon 251418.39890
GSM201831Muscle PCOS pioglitazone 271421.74289
GSM201832Muscle PCOS pioglitazone 31398.40989
GSM201833Muscle PCOS pioglitazone 41351.37287
GSM201834Muscle PCOS pioglitazone 81422.15289
GSM201835Muscle PCOS after pioglitazone 102364.46286
GSM201836Muscle PCOS after pioglitazone 122342.81685
GSM201837Muscle PCOS after pioglitazone 162359.39687
GSM201838Muscle PCOS after pioglitazone 202406.3387
GSM201839Muscle PCOS after pioglitazone 232303.37382
GSM201840Muscle PCOS after pioglitazone 252348.70884
GSM201841Muscle PCOS after pioglitazone 272317.44184
GSM201842Muscle PCOS after pioglitazone 32313.56985
GSM201843Muscle PCOS after pioglitazone 4237087
GSM201844Muscle PCOS after pioglitazone 82405.59488